CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · IEX Real-Time Price · USD
1.260
-0.160 (-11.27%)
At close: Jul 2, 2024, 4:00 PM
1.280
+0.020 (1.59%)
After-hours: Jul 2, 2024, 7:56 PM EDT
CNS Pharmaceuticals Market Cap
CNS Pharmaceuticals has a market cap or net worth of $298.67 thousand as of July 2, 2024. Its market cap has decreased by -96.92% in one year.
Market Cap
298.67K
Enterprise Value
-303.45K
1-Year Change
-96.92%
Ranking
Category
Stock Price
$1.26
Market Cap Chart
Since November 8, 2019, CNS Pharmaceuticals's market cap has decreased from $71.80M to $298.67K, a decrease of -99.58%. That is a compound annual growth rate of -69.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 300.00K | -95.52% |
| Dec 29, 2023 | 6.70M | 109.38% |
| Dec 30, 2022 | 3.20M | -83.67% |
| Dec 31, 2021 | 19.60M | -33.78% |
| Dec 31, 2020 | 29.60M | -54.46% |
| Dec 31, 2019 | 65.00M | -9.47% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lucy Scientific Discovery | 906.91K |
| China SXT Pharmaceuticals | 782.44K |
| GRI Bio | 558.94K |
| Applied DNA Sciences | 461.44K |
| Bluejay Diagnostics | 392.01K |
| Biodexa Pharmaceuticals | 208.34K |